前瞻性IETA-4队列中超声评估肿瘤范围及预测高危子宫内膜癌策略的验证
基于国际子宫内膜肿瘤分析(IETA)-4前瞻性多中心队列1538例子宫内膜癌患者,比较主观超声评估与超声测量预测深肌层浸润和宫颈间质浸润的效能,并验证两种两步策略预测高危癌。主观评估预测深肌层浸润优于测量,尤其低级别肿瘤;联合主观评估与活检分级或主观两步策略预测高危癌准确率均达80%。
要点
- 主观超声评估预测深肌层浸润的敏感度/特异度:低级别肿瘤70%/80%,高级别或非子宫内膜样肿瘤76%/64%。
- 主观超声评估预测宫颈间质浸润的敏感度/特异度:低级别肿瘤51%/94%,高级别或非子宫内膜样肿瘤50%/91%。
- 肿瘤前后径及肿瘤/子宫前后径比值预测深肌层浸润AUC分别为0.76和0.77,肿瘤下缘至宫颈外口距离预测宫颈间质浸润AUC为0.72。
核心结论
- 在有经验的超声检查者手中,主观超声评估预测子宫内膜癌深肌层浸润和宫颈间质浸润优于超声测量,尤其在Grade-1或-2肿瘤患者中。
- 预测高危子宫内膜癌的最佳策略为联合主观评估与活检分级以及主观两步策略,两者准确率均为80%。
- 高危癌数学预测模型表现符合预期,主观和客观模型应用于Grade-1和-2子宫内膜样肿瘤时AUC分别为0.76和0.75。
研究设计与样本
- 国际子宫内膜肿瘤分析(IETA)-4前瞻性多中心研究,纳入1538例子宫内膜癌患者,均接受标准化专家经阴道超声检查。
- 以子宫切除术后组织学评估为参考标准。
- 评估主观超声评估和超声测量预测深肌层浸润及宫颈间质浸润的效能,并验证已发表的测量截断值和预测模型。
- 验证两种两步策略预测高危癌:第一步将活检证实的Grade-3子宫内膜样、黏液性或非子宫内膜样癌归为高危癌,第二步应用数学模型对其余肿瘤分类。
- 主观预测模型变量包括活检分级(Grade 1 vs Grade 2)和深肌层浸润或宫颈间质浸润的主观评估(存在或不存在);客观预测模型变量包括活检分级(Grade 1 vs Grade 2)和最小无肿瘤边缘。
诊断标准与关键数值
- 在1275例可测量病灶患者中,主观超声评估预测深肌层浸润的敏感度和特异度:Grade-1或-2子宫内膜样或黏液性肿瘤患者为70%和80%,Grade-3子宫内膜样或黏液性或非子宫内膜样肿瘤患者为76%和64%。
- 主观超声评估预测宫颈间质浸润的敏感度和特异度:Grade-1或-2子宫内膜样或黏液性肿瘤患者为51%和94%,Grade-3子宫内膜样或黏液性或非子宫内膜样肿瘤患者为50%和91%。
- 肿瘤前后径和肿瘤/子宫前后径比值预测深肌层浸润效能最佳,AUC分别为0.76和0.77;肿瘤下缘至宫颈外口距离预测宫颈间质浸润效能最佳,AUC为0.72。
- 简单联合主观评估与活检分级将患者分类为高危癌的准确率为80%,主观两步策略和客观两步策略的准确率分别为80%和74%。
- 主观和客观模型应用于Grade-1和-2子宫内膜样肿瘤时AUC分别为0.76和0.75。
临床应用与阅片要点
- 在有经验的超声检查者中,主观评估预测深肌层浸润和宫颈间质浸润优于超声测量,尤其对于Grade-1或-2肿瘤患者。
- 预测高危子宫内膜癌时,联合主观评估与活检分级或采用主观两步策略的准确率均为80%,优于客观两步策略的74%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare the performance of ultrasound measurements and subjective ultrasound assessment (SA) in detecting deep myometrial invasion (MI) and cervical stromal invasion (CSI) in women with endometrial cancer, overall and according to whether they had low- or high-grade disease separately, and to validate published measurement cut-offs and prediction models to identify MI, CSI and high-risk disease (Grade-3 endometrioid or non-endometrioid cancer and/or deep MI and/or CSI).
METHODS: The study comprised 1538 patients with endometrial cancer from the International Endometrial Tumor Analysis (IETA)-4 prospective multicenter study, who underwent standardized expert transvaginal ultrasound examination. SA and ultrasound measurements were used to predict deep MI and CSI. We assessed the diagnostic accuracy of the tumor/uterine anteroposterior (AP) diameter ratio for detecting deep MI and that of the distance from the lower margin of the tumor to the outer cervical os (Dist-OCO) for detecting CSI. We also validated two two-step strategies for the prediction of high-risk cancer; in the first step, biopsy-confirmed Grade-3 endometrioid or mucinous or non-endometrioid cancers were classified as high-risk cancer, while the second step encompassed the application of a mathematical model to classify the remaining tumors. The 'subjective prediction model' included biopsy grade (Grade 1 vs Grade 2) and subjective assessment of deep MI or CSI (presence or absence) as variables, while the 'objective prediction model' included biopsy grade (Grade 1 vs Grade 2) and minimal tumor-free margin. The predictive performance of the two two-step strategies was compared with that of simply classifying patients as high risk if either deep MI or CSI was suspected based on SA or if biopsy showed Grade-3 endometrioid or mucinous or non-endometrioid histotype (i.e. combining SA with biopsy grade). Histological assessment from hysterectomy was considered the reference standard.
RESULTS: In 1275 patients with measurable lesions, the sensitivity and specificity of SA for detecting deep MI was 70% and 80%, respectively, in patients with a Grade-1 or -2 endometrioid or mucinous tumor vs 76% and 64% in patients with a Grade-3 endometrioid or mucinous or a non-endometrioid tumor. The corresponding values for the detection of CSI were 51% and 94% vs 50% and 91%. Tumor AP diameter and tumor/uterine AP diameter ratio showed the best performance for predicting deep MI (area under the receiver-operating characteristics curve (AUC) of 0.76 and 0.77, respectively), and Dist-OCO had the best performance for predicting CSI (AUC, 0.72). The proportion of patients classified correctly as having high-risk cancer was 80% when simply combining SA with biopsy grade vs 80% and 74% when using the subjective and objective two-step strategies, respectively. The subjective and objective models had an AUC of 0.76 and 0.75, respectively, when applied to Grade-1 and -2 endometrioid tumors.
CONCLUSIONS: In the hands of experienced ultrasound examiners, SA was superior to ultrasound measurements for the prediction of deep MI and CSI of endometrial cancer, especially in patients with a Grade-1 or -2 tumor. The mathematical models for the prediction of high-risk cancer performed as expected. The best strategies for predicting high-risk endometrial cancer were combining SA with biopsy grade and the subjective two-step strategy, both having an accuracy of 80%. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Verbakel JY, Mascilini F, Wynants L, et al. Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (International Endometrial Tumor Analysis)-4 cohort. Ultrasound Obstet Gynecol. 2019. PMID: 31225683. doi:10.1002/uog.20374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。